Tag: Bayer

8/16/2017

Investors aren’t the only ones burned by misleading drug company news releases

2/9/2017

‘Overwhelming efficacy’ or ‘tiny effect size’? Bayer’s data-free claims on blood-thinner study extend troubling PR trend

4 12/9/2015

Is it ok for journalists to attend Bayer-funded training on new cancer treatments?

5 9/23/2015

Better late than never, FDA to hold long overdue safety hearing on Essure sterilization device

Blog

Opinions on other issues in news, journals, PR, advertising, marketing

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

Jill U Adams @juadams·

One sentence from an @npr story about #opioids prompted twitter rage amongst #addiction specialists. I took a closer look at the issue - an insurance barrier called prior authorization - for @HealthNewsRevu. @jonathan_giftos @LarochelleMarc @maiasz https://t.co/QgL8K8zJUD

Reply on Twitter Retweet on Twitter2 Like on Twitter1 Twitter

HealthNewsReview.org @HealthNewsRevu·

Smartphone device’s early lab results no substitute for real-world infectious disease detection https://t.co/0d6MuHekD9

Reply on Twitter Retweet on Twitter1 Like on Twitter Twitter

HealthNewsReview.org @HealthNewsRevu·

Insurance company red tape: a potentially deadly barrier to opioid addiction treatment. By @juadams
https://t.co/pxQIEkPeuu

Reply on Twitter Retweet on Twitter Like on Twitter1 Twitter